Scienture Holdings Inc
SCNX1.900USD
-0.010-0.52%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
23.78MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Scienture Holdings Inc Unternehmen
Scienture Holdings, Inc., formerly TRxADE Health, Inc., is a comprehensive health services and pharmaceutical product company focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs, optimize the prescription journey and patient engagement in the United States. It operates through Scienture, LLC and Integra Pharma Solutions, LLC. Scienture, LLC is a branded specialty pharmaceutical company. Its assets in development are across therapeutics areas, indications and cater to different market segments. Its products include SCN - 102 (Cardiovascular), SCN - 104 (CNS-Pain), SCN - 105 (CNS), SCN - 106 (Cardiovascular) and SCN - 107 (Pain). Integra Pharma Solutions, LLC is the pharmaceutical supplier of choice for healthcare organizations of all sizes. Its expertise in the distribution of products extends to all healthcare markets including government organizations, hospitals, clinics, and independent pharmacies nationwide.
Unternehmensinformationen
BörsenkürzelSCNX
Name des UnternehmensScienture Holdings Inc
IPO-datumFeb 18, 2020
CEODr. Narasimhan Mani
Anzahl der mitarbeiter14
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 18
Addresse- -
Stadt- -
BörseNASDAQ Capital Market Consolidated
Land- -
Postleitzahl- -
Telefon- -
Website- -
BörsenkürzelSCNX
IPO-datumFeb 18, 2020
CEODr. Narasimhan Mani
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Narasimhan Mani
Dr. Narasimhan Mani
President, Co-Chief Executive Officer, Director
President, Co-Chief Executive Officer, Director
1.42M
--
Dr. Shankar Hariharan, Ph.D.
Dr. Shankar Hariharan, Ph.D.
Executive Chairman of the Board, Co-Chief Executive Officer
Executive Chairman of the Board, Co-Chief Executive Officer
--
--
Mr. Subbarao Jayanthi
Mr. Subbarao Jayanthi
Independent Director
Independent Director
--
--
Mr. Mayur Doshi
Mr. Mayur Doshi
Independent Director
Independent Director
--
--
Mr. Donald G. Fell
Mr. Donald G. Fell
Independent Director
Independent Director
--
--
Mr. Eric Sherb
Mr. Eric Sherb
Chief Financial Officer
Chief Financial Officer
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Narasimhan Mani
Dr. Narasimhan Mani
President, Co-Chief Executive Officer, Director
President, Co-Chief Executive Officer, Director
1.42M
--
Dr. Shankar Hariharan, Ph.D.
Dr. Shankar Hariharan, Ph.D.
Executive Chairman of the Board, Co-Chief Executive Officer
Executive Chairman of the Board, Co-Chief Executive Officer
--
--
Mr. Subbarao Jayanthi
Mr. Subbarao Jayanthi
Independent Director
Independent Director
--
--
Mr. Mayur Doshi
Mr. Mayur Doshi
Independent Director
Independent Director
--
--
Mr. Donald G. Fell
Mr. Donald G. Fell
Independent Director
Independent Director
--
--
Mr. Eric Sherb
Mr. Eric Sherb
Chief Financial Officer
Chief Financial Officer
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2024
Keine Daten
Nach RegionUSD
Name
Umsatz
Anteil
United States
136.64K
0.00%
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionärsstatistik
Aktualisiert: Wed, Jul 2
Aktualisiert: Wed, Jul 2
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Hariharan (Shankar Ph.D.)
17.09%
Mani (Narasimhan)
10.20%
Ajjarapu (Surendra K)
1.51%
Patel Prashant
1.27%
Doshi (Mayur Mansukhlal)
0.48%
Other
69.44%
Aktionäre
Aktionäre
Anteil
Hariharan (Shankar Ph.D.)
17.09%
Mani (Narasimhan)
10.20%
Ajjarapu (Surendra K)
1.51%
Patel Prashant
1.27%
Doshi (Mayur Mansukhlal)
0.48%
Other
69.44%
Aktionärstypen
Aktionäre
Anteil
Individual Investor
30.81%
Hedge Fund
0.61%
Investment Advisor
0.43%
Investment Advisor/Hedge Fund
0.23%
Other
67.92%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
28
4.45M
32.09%
+15.20K
2025Q1
32
4.45M
33.93%
+9.47K
2024Q4
36
4.62M
68.10%
+3.89M
2024Q3
36
1.01M
65.38%
+269.18K
2024Q2
37
1.00M
67.44%
+530.62K
2024Q1
34
476.38K
36.25%
+95.67K
2023Q4
35
386.59K
47.32%
+20.29K
2023Q3
38
376.26K
55.40%
-6.85K
2023Q2
38
402.57K
59.37%
+44.99K
2023Q1
42
365.94K
58.68%
-79.79K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Hariharan (Shankar Ph.D.)
2.37M
18.07%
--
--
Jan 27, 2025
Mani (Narasimhan)
1.42M
10.79%
--
--
Jan 27, 2025
Ajjarapu (Surendra K)
210.10K
1.6%
--
--
Jan 27, 2025
Patel Prashant
176.69K
1.35%
--
--
Jan 27, 2025
Doshi (Mayur Mansukhlal)
66.45K
0.51%
--
--
Jan 27, 2025
Armistice Capital LLC
65.50K
0.5%
+36.65K
+127.04%
Dec 31, 2023
Susquehanna International Group, LLP
37.41K
0.29%
+37.41K
--
Mar 31, 2025
Fell (Donald G.)
35.16K
0.27%
--
--
Jan 27, 2025
Geode Capital Management, L.L.C.
32.16K
0.25%
+11.60K
+56.41%
Mar 31, 2025
Millennium Management LLC
14.68K
0.11%
-19.30K
-56.80%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Name
Anteil
Keine Daten
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Jun 21, 2023
Merger
15<1
Jun 21, 2023
Merger
15<1
Jun 21, 2023
Merger
15<1
Jun 21, 2023
Merger
15<1
Datum
Art
Verhältnis
Jun 21, 2023
Merger
15<1
Jun 21, 2023
Merger
15<1
Jun 21, 2023
Merger
15<1
Jun 21, 2023
Merger
15<1
